Genmab US, Inc.

H-1B Sponsorship & Salary Data — Government-Verified

$200,883Avg. Salary
13Filings
13+Job Titles
December 2025Last Filing

According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), Genmab US, Inc. pays a median H-1B salary of $189,660 — 56% above the national median of $121,514, ranking in the top 7% of 13,957 ranked H-1B sponsors. Based on 13 certified Labor Condition Applications.

Section 1

What does Genmab US, Inc. pay?

Genmab US, Inc.'s H-1B filings show an average salary of $200,883 based on 13 certified LCA applications. Salaries range from $152,397 to $311,021.

$200,883
Average
$189,660
Median
$152,397
Minimum
$311,021
Maximum

Recent H-1B Filings

Job TitleSalaryLocationDate
Associate Director, Digital Solutions $194,742 Plainsboro, NJ Dec 2025
Senior Manager, Real World Data & Epidemiology Analytics $152,397 Plainsboro, NJ Nov 2025
Principal Tech Lead, SAP App Development, Enabling Functions $204,699 Plainsboro, NJ Sep 2025
Senior Manager, Biostatistics $175,781 Plainsboro, NJ Aug 2025
Senior Director, Data Products, Research & Enabling Function $261,500 Plainsboro, NJ Aug 2025
Associate Director - US Market Solutions $158,974 Plainsboro, NJ Aug 2025
Director, Commercial Data Science $232,920 Plainsboro, NJ Jul 2025
Senior Commercial Data Engineer $189,660 Plainsboro, NJ May 2025
Associate Director, Global Drug Safety and Pharmacovigilance $186,022 Plainsboro, NJ Mar 2025
Associate Corporate Counsel $155,000 Plainsboro, NJ Jan 2025
Vice President, Global Digital Products, R&D $311,021 Plainsboro, NJ Dec 2024
Assoc Dir, Global Drug Safety & Pharmacovgilance Physician $218,764 Plainsboro, NJ Nov 2024
Senior Project Manager, Global Clinical Drug Supply $170,000 Plainsboro, NJ Oct 2024
Section 2

States with Genmab US, Inc. H-1B Filings

Section 3

All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.

Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.